Abstract:Animal models have facilitated basic neuroscience research investigating the pathophysiology of tinnitus. It has been hypothesized that partial deafferentation produces a loss of tonic inhibition in the auditory system that may lead to inappropriate neuroplastic changes eventually expressed as tinnitus. The pathological down-regulation of gamma-amino butyric acid (GABA) provides a potential mechanism for this loss of inhibition. Using an animal model previously demonstrated to be sensitive to treatments that either induce or attenuate tinnitus, the present study examined the effect of the specific GABA agonist vigabatrin on chronic tinnitus. It was hypothesized that vigabatrin would decrease the evidence of tinnitus by restoring central inhibitory function through increased GABA availability. Vigabatrin has been demonstrated to elevate central GABA levels (Mattson et al. 1995). Tinnitus was induced in rats using a single 1-h unilateral exposure to band-limited noise, which preserved normal hearing in one ear. Psychophysical evidence of tinnitus was obtained using a free-operant conditioned-suppression method: Rats lever-pressed for food pellets and were trained to discriminate between the presence and absence of sound by punishing lever pressing with a mild foot shock (0.5 mA; 1 s) at the conclusion of randomly introduced silent periods (60 s) inserted into background low-level noise. Additional random insertion of pure tone and noise periods of variable intensity enabled the derivation of psychophysical functions that reflected the presence of tinnitus with features similar to 20-kHz tones. Vigabatrin was chronically administered via drinking water at 30 and 81 mg kg-1 day-1, with each dose level tested over 2 weeks, followed by a 0-mg washout test. Vigabatrin completely and reversibly eliminated the psychophysical evidence of tinnitus at both doses. Although vigabatrin has serious negative side effects that have prevented its clinical use in the USA, it is nevertheless a potentially useful tool in unraveling tinnitus pathophysiology.

Effects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in rats

Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice

Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats

Glial Modulation of Vibrissal Sensory Processing in Rats.

Low-Dose Vigabatrin (γ-Vinyl GABA)-Induced Damage in the Immature Rat Brain

Treatment of Epilepsy: the Gaba-Transaminase Inhibitor, Vigabatrin, Induces Neuronal Plasticity in the Mouse Retina

Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model

Effect of GABA-T on Reproductive Function in Female Rats

Effect of Vagus Nerve Stimulation on Thermal Injury in Rats.

Dose-response relationship analysis of vigabatrin doses and their antinociceptive effects in the hot-plate test in mice

Hypoalgesia in mice lacking GABA transporter subtype 1

[Ethanol Affects the Function of Gamma-Aminobutyric Acid Transporter I in Mice Brain].

Reduced Aggression in Mice Lacking GABA Transporter Subtype 1.

A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent

Differential toxic and antiepileptic features of Vigabatrin raceme and its enantiomers

GABA in Paraventricular Nucleus Regulates Adipose Afferent Reflex in Rats

Opposing actions of co-released GABA and neurotensin on the activity of preoptic neurons and on body temperature

Modulation of vigabatrin induced cerebellar injury: the role of caspase-3 and RIPK1/RIPK3-regulated cell death pathways

Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity.

Effects of vigabatrin on the skeletal system of young rats

Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms